Inhibition of secretory phospholipase A2 enzyme by bilirubin: A new role as endogenous anti-inflammatory molecule

Molecular and Cellular Biochemistry

Volumn 276, Issue 1-2, 2005, Pages 219-225

  Jameel, Noor Mohamed ^a   Frey, Brigitte M ^b   Frey, Felix J ^b   Gowda, T Veerabasappa ^a   Vishwanath, Bannikuppe S ^a  

^a UNIVERSITY OF MYSORE   (India)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Anti inflammatory; Bilirubin; Endogenous inhibitor; Secretory phospholipase A2

Indexed keywords

BILIRUBIN; CALCIUM; CHOLESTEROL OLEATE; PHOSPHOLIPASE A2; SNAKE VENOM;

ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASCITES FLUID; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PURIFICATION; ENZYME REGULATION; ESCHERICHIA COLI; FLUORESCENCE; IC 50; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PAW EDEMA; PLEURA FLUID; PROTEIN INTERACTION; SNAKE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ASCITIC FLUID; BILIRUBIN; CALCIUM; CATTLE; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; HUMANS; INHIBITORY CONCENTRATION 50; PHOSPHOLIPASES A; PLEURAL CAVITY; SNAKE VENOMS; SNAKES; SPECTROMETRY, FLUORESCENCE;

DABOIA RUSSELII; ESCHERICHIA COLI; NAJA NAJA;

EID: 24144481921     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-005-4441-x     Document Type: Article

References (32)

1. 2 in eicosanoid generation. Am J Respir Crit Care Med 161(2 Pt 2): S32-S35, 2000 10673223
2. 2 research. J Lipid Mediat 2: 159-172, 1990 2133269
3. Six DA, Dennis EA: The expanding superfamily of phospholipase A(2) enzymes: Classification and characterization. Biochim Biophys Acta 1488: 1-19, 2000 11080672
4. 2 and their pathophysiological significance in inflammatory diseases. Curr Mol Med 1: 739-754, 2001 10.2174/1566524013363258
5. 2. Annu Rev Pharmacol Toxicol 39: 175-189, 1999 10.1146/annurev.pharmtox.39.1.175
6. 2. Toxicon 42: 947-962, 2003 10.1016/j.toxicon.2003.11.006
7. 2 induces an inflammatory response in rabbit joints. J Immunol 146: 3904-3910, 1991 2033260
8. 2 by retenoids and falvonoids. Mechanism of action. Inflammation 12: 549-561, 1988
9. 2 -induced pleural inflammation in rats. Int J Tissue React 11: 129-136, 1989 2533186
10. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN: Bilirubin is an antioxidant of possible physiological importance. Science 235: 1043-1046, 1987 3029864
11. Minetti M, Mallozzi C, Di Stasi AM, Pietraforte D: Bilirubin is an effective antioxidant of peroxynitrite-mediated protein oxidation in human blood plasma. Arch Biochem Biophys 352: 165-174, 1998 10.1006/ abbi.1998.0584
12. Mayer M: Association of serum bilirubin concentration with risk of coronary artery disease. Clin Chem 46: 1723-1727, 2000 11067805
13. Nakagami T, Toyomura K, Kinoshita T, Morisawa S: A beneficial role of bile pigments as an endogenous tissue protector: Anti-complement effects of biliverdin and conjugated bilirubin. Biochim Biophys Acta 1158: 189-193, 1993 8399320
14. 2 and its Regulatory Factors Plenum press New york 219
15. 2 from Russell's viper (Vipera russelli) venom. Toxicon 27: 229-237, 1989 10.1016/0041-0101(89)90136-0
16. 2 from Indian cobra (Naja naja naja) venom. Toxicon 36: 921-932, 1998 10.1016/S0041-0101(97)00097-4
17. Patriarca P, Beckerdite S, Elsbach P: Phospholipases and phospholipid turnover in Escherichia coli spheroplasts. Biochim Biophys Acta 260: 593-600, 1972 4623878
18. 2 activity in rats. J Clin Invest 98: 365-371, 1996 8755646
19. www.embl-heidelberg.de/~andrade/k2dfaq.html.
20. MM Yamakawa NZ Hokama 1976 Fractionation of Sakishima habu (T. elegans) venom and lethal hemorrhagic and edema forming activity of the fractions In: A. Ohsaka K. Hayashi Y. Sawai (eds) Animal Plant and Microbial Toxins, Vol 1 Plenum press New york 97
21. Chakraborti S: PhospholApase A(2) isoforms: a perspective. Cell Signal 15: 637-665, 2003 10.1016/S0898-6568(02)00144-4
22. Deepa M, Veerabasappa Gowda T: Purification and characterization of a glycoprotein inhibitor of toxic phospholipase from Withania somnifera. Arch Biochem Biophys 408: 42-50, 2002 10.1016/S0003-9861(02)00527-1
23. 2 by minocycline and doxycycline. Biochem Pharmacol 44: 1165-1170, 1992 10.1016/0006-2952(92)90381-R
24. 2: function and pharmacological regulation. Biochem Pharmacol 36: 2429-2436, 1987 10.1016/0006-2952(87)90512-0
25. 2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids. J Biol Chem 262: 1698-1705, 1987 2948959
26. 2 by retinoids and flavonoids. Mechanism of action. Agents Actions 25(3-4): 394-400, 1988 10.1007/BF01965048
27. SY Venyaminov JT Yang 1996 Determination of protein secondary structure In: G.D. Fasman (eds)Circular Dichroism and the Conformational Analysis of Biomolecules Plenum Press New York 69
28. Lin YH, Huang WN, Lee SC, Wu WG: Heparin reduces the alpha-helical content of cobra basic phospholipase A(2) and promotes its complex formation. Int J Biol Macromol 27(2): 171-176, 2000 10.1016/ S0141-8130(00)00117-3
29. Vishwanath BS, Appu Rao AG, Gowda TV: Interaction of phospholipase A 2 from Vipera russelli venom with aristolochic acid: A circular dichroism study. Toxicon 25: 939-946, 1987 10.1016/0041-0101(87)90156-5
30. 2 purified from human synovial fluid and inhibition by aristolochic acid. Inflammation 12: 549-561, 1988 10.1007/ BF00914317
31. Sala A, Recio MC, Giner RM, Manez S, Rios JL: Anti-phospholipase A 2 and anti-inflammatory activity of Santolina chamaecyparissus. Life Sci 66: PL35-PL40, 2000 10.1016/S0024-3205(99)00578-0
32. 2 activity in hyperbilirubinemia. Hepatogastroenterology 47: 1223-1226, 2000 11100318